Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Japanese Journal of Clinical Oncology|August 14, 2018
Proteasome inhibitors for multiple myelomaKiyoshi Okazuka, Tadao Ishida
Future Oncology (London, England)|November 4, 2022
Practice patterns and outcomes for triple-class exposed patients with relapsed/refractory multiple myeloma in JapanShinsuke Iida, Mayuko Nakakoji, Dionysis Spanopoulos, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 4, 2006
Expression of TCR alpha beta partly rescues developmental arrest and apoptosis of alpha beta T cells in Bcl11b-/- miceJun Inoue, Tsutomu Kanefuji, Kiyoshi Okazuka, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|June 1, 2025
Postmarketing surveillance of brentuximab vedotin for previously untreated Hodgkin lymphoma in Japanese patientsKiyoshi Okazuka, Takayuki Shimizu, Ryosuke Tawara, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 6, 2018
[Carfilzomib, lenalidomide, and dexamethasone therapy for refractory and relapsed multiple myeloma: a single-center study of 29 patients]Kiyoshi Okazuka, Tadao Ishida, Kota Sato, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 21, 2018
[A Case of Drug-Induced Organizing Pneumonia Caused by Dasatinib]Miyuki Sato, Satoshi Watanabe, Nobumasa Aoki, et al.
International Journal of Hematology|November 9, 2007
Successful all-trans retinoic acid treatment of acute promyelocytic leukemia in a patient with NPM/RAR fusionKiyoshi Okazuka, Masayoshi Masuko, Yoshinobu Seki, et al.
Pageof 4